Nuclear b b-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in

[1]  A. Rydholm,et al.  Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. , 2005, Human pathology.

[2]  M. Ladanyi,et al.  E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma , 2004, Oncogene.

[3]  M. Ozturk,et al.  p53 mutation as a source of aberrant β-catenin accumulation in cancer cells , 2002, Oncogene.

[4]  Yusuke Nakamura,et al.  Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. , 2002, Cancer research.

[5]  Tsuyoshi Saito,et al.  β-Catenin Accumulation and Gene Mutation in Exon 3 in Dedifferentiated Liposarcoma and Malignant Fibrous Histiocytoma , 2002 .

[6]  K. Shimotohno,et al.  Wnt/β‐catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts , 2002, International journal of cancer.

[7]  E. Hay,et al.  DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT , 2002, Cell biology international.

[8]  Tsuyoshi Saito,et al.  APC mutations in synovial sarcoma , 2002, The Journal of pathology.

[9]  Y. Iwamoto,et al.  Matrix metalloproteinase‐2 expression correlates with morphological and immunohistochemical epithelial characteristics in synovial sarcoma , 2002, Histopathology.

[10]  K. Sugimachi,et al.  E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. , 2001, The American journal of pathology.

[11]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[12]  Tsuyoshi Saito,et al.  β‐catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours , 2001, The Journal of pathology.

[13]  A. M. Arias.  Epithelial Mesenchymal Interactions in Cancer and Development , 2001, Cell.

[14]  A. Nakagawara,et al.  Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  S. Hirohashi,et al.  Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. , 2001, Human pathology.

[16]  N. Kinukawa,et al.  Prognostic value of the preserved expression of the E‐cadherin and catenin families of adhesion molecules and of β‐catenin mutations in synovial sarcoma , 2000, The Journal of pathology.

[17]  K. Müller,et al.  β-Catenin in Soft tissue Sarcomas: Expression is Related to Proliferative Activity in High-Grade Sarcomas , 2000, Modern Pathology.

[18]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[19]  M. Ladanyi,et al.  Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. , 2000, The American journal of pathology.

[20]  M. Ladanyi,et al.  Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[21]  Thomas Kirchner,et al.  β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer , 1999 .

[22]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[23]  Elaine Fuchs,et al.  A common human skin tumour is caused by activating mutations in β-catenin , 1999, Nature Genetics.

[24]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[25]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[26]  S. Albrecht,et al.  Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. , 1999, Cancer research.

[27]  C. Cordon-Cardo,et al.  Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[29]  S. Hirohashi,et al.  Beta-catenin mutation in carcinoma of the uterine endometrium. , 1998, Cancer research.

[30]  S. Hirohashi.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. , 1998, The American journal of pathology.

[31]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[32]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[33]  J. Palacios,et al.  Mutations in the β-Catenin Gene (CTNNB1) in Endometrioid Ovarian Carcinomas , 1998 .

[34]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[35]  C. Raffel,et al.  Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations , 1998 .

[36]  M. Ladanyi,et al.  SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. , 1998, The New England journal of medicine.

[37]  Y. Yuasa,et al.  Analyses of the APC and TGF‐β Type II Receptor Genes, and Microsatellite Instability in Mucosal Colorectal Carcinomas , 1997, Japanese journal of cancer research : Gann.

[38]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[39]  R. West,et al.  Nuclear beta-catenin in mesenchymal tumors , 2005, Modern Pathology.

[40]  Tsuyoshi Saito,et al.  Possible Association Between Higher β-Catenin mRNA Expression and Mutated β-Catenin in Sporadic Desmoid Tumors: Real-Time Semiquantitative Assay by TaqMan Polymerase Chain Reaction , 2002, Laboratory Investigation.

[41]  M. Ladanyi,et al.  Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. , 2002, Cancer research.

[42]  Masafumi Nakamura,et al.  Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.